【2931】ユーグレナ
機能性食品・化粧品の販売
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 | 日付 | 予・実 | 売上高 (百万円) |
対前回 | 修正率 | 修正率 | 営業利益 (百万円) |
対前回 | 修正率 | 修正率 | 経常利益 (百万円) |
対前回 | 修正率 | 修正率 | 当期利益 (百万円) |
対前回 | 修正率 | 修正率 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023.12 | 2024/02/14 | 実 | 46,482 | - | - | - | -1,464 | - | - | - | -1,419 | - | - | - | -2,652 | - | - | - |
2022.12 | 2023/02/13 | 実 | 44,392 | - | - | - | -3,455 | - | - | - | -2,489 | - | - | - | -2,672 | - | - | - |
2021.12 | 2022/02/10 | 実 | 34,420 | - | - | - | -6,565 | - | - | - | -6,354 | - | - | - | -5,038 | - | - | - |
2020.09 | 2020/11/13 | 実 | 13,317 | ↑ | +0.1% | +0.1% | -1,807 | ↓ | -50.6% | -50.6% | -1,457 | ↓ | -71.4% | -71.4% | -1,486 | ↓ | -65.1% | -65.1% |
2020.09 | 2020/02/10 | Q1予 | 13,300 | → | 0.0% | 0.0% | -1,200 | → | 0.0% | 0.0% | -850 | → | 0.0% | 0.0% | -900 | → | 0.0% | 0.0% |
2020.09 | 2019/11/08 | 当初予 | 13,300 | - | - | - | -1,200 | - | - | - | -850 | - | - | - | -900 | - | - | - |
2019.09 | 2019/11/08 | 実 | 13,967 | ↓ | -15.4% | -15.4% | -7,460 | ↓ | -9.8% | -9.8% | -7,073 | ↓ | -11.0% | -11.0% | -9,798 | ↓ | -46.8% | -46.8% |
2019.09 | 2019/08/08 | Q3予 | 16,500 | → | 0.0% | 0.0% | -6,793 | → | 0.0% | 0.0% | -6,373 | → | 0.0% | 0.0% | -6,673 | → | 0.0% | 0.0% |
2019.09 | 2019/05/14 | Q2予 | 16,500 | → | 0.0% | 0.0% | -6,793 | → | 0.0% | 0.0% | -6,373 | → | 0.0% | 0.0% | -6,673 | → | 0.0% | 0.0% |
2019.09 | 2019/02/08 | Q1予 | 16,500 | → | 0.0% | 0.0% | -6,793 | → | 0.0% | 0.0% | -6,373 | → | 0.0% | 0.0% | -6,673 | → | 0.0% | 0.0% |
2019.09 | 2018/11/07 | 当初予 | 16,500 | - | - | - | -6,793 | - | - | - | -6,373 | - | - | - | -6,673 | - | - | - |
2018.09 | 2018/11/07 | 実 | 15,174 | ↑ | +1.2% | +1.2% | -1,379 | ↑ | +23.4% | +23.4% | -1,096 | ↑ | +26.9% | +26.9% | -1,252 | ↑ | +24.1% | +24.1% |
2018.09 | 2018/08/07 | Q3予 | 15,000 | → | 0.0% | 0.0% | -1,800 | - | - | - | -1,500 | → | 0.0% | 0.0% | -1,650 | → | 0.0% | 0.0% |
2018.09 | 2018/05/11 | 当初予 | 15,000 | - | - | - | - | - | - | - | -1,500 | - | - | - | -1,650 | - | - | - |
2017.09 | 2017/11/10 | 実 | 13,886 | ↓ | -7.4% | -7.4% | 950 | ↑ | +15.9% | +15.9% | 1,207 | ↑ | +9.7% | +9.7% | 785 | ↑ | +13.8% | +13.8% |
2017.09 | 2017/08/07 | Q3予 | 15,000 | → | 0.0% | 0.0% | 820 | → | 0.0% | 0.0% | 1,100 | → | 0.0% | 0.0% | 690 | → | 0.0% | 0.0% |
2017.09 | 2017/05/12 | Q2予 | 15,000 | → | 0.0% | 0.0% | 820 | → | 0.0% | 0.0% | 1,100 | → | 0.0% | 0.0% | 690 | → | 0.0% | 0.0% |
2017.09 | 2017/02/10 | 当初予 | 15,000 | - | - | - | 820 | - | - | - | 1,100 | - | - | - | 690 | - | - | - |
2016.09 | 2016/11/09 | 実 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
2016.09 | 2016/08/12 | Q3予 | 11,100 | ↑ | +0.1% | +0.1% | 760 | ↑ | +26.5% | +26.5% | 1,000 | ↑ | +21.1% | +21.1% | 736 | ↑ | +36.3% | +36.3% |
2016.09 | 2016/05/13 | Q2予 | 11,086 | → | 0.0% | 0.0% | 601 | → | 0.0% | 0.0% | 826 | → | 0.0% | 0.0% | 540 | → | 0.0% | 0.0% |
2016.09 | 2016/02/12 | Q1予 | 11,086 | → | 0.0% | 0.0% | 601 | → | 0.0% | 0.0% | 826 | → | 0.0% | 0.0% | 540 | → | 0.0% | 0.0% |
2016.09 | 2015/11/13 | 当初予 | 11,086 | - | - | - | 601 | - | - | - | 826 | - | - | - | 540 | - | - | - |
2015.09 | 2015/11/13 | 実 | 5,924 | ↑ | +0.0% | +25.5% | 476 | ↑ | +47.4% | +518.2% | 726 | ↑ | +35.4% | +842.9% | 469 | ↑ | +36.3% | +168.0% |
2015.09 | 2015/08/13 | 修正予 | 5,923 | → | 0.0% | +25.4% | 323 | ↑ | +25.2% | +319.5% | 536 | ↑ | +39.6% | +596.1% | 344 | ↑ | +46.4% | +96.6% |
2015.09 | 2015/05/13 | 修正予 | 5,923 | ↑ | +25.4% | +25.4% | 258 | ↑ | +235.1% | +235.1% | 384 | ↑ | +398.7% | +398.7% | 235 | ↑ | +34.3% | +34.3% |
2015.09 | 2015/02/13 | Q1予 | 4,722 | → | 0.0% | 0.0% | 77 | → | 0.0% | 0.0% | 77 | → | 0.0% | 0.0% | 175 | → | 0.0% | 0.0% |
2015.09 | 2014/11/13 | 当初予 | 4,722 | - | - | - | 77 | - | - | - | 77 | - | - | - | 175 | - | - | - |
2014.09 | 2014/11/13 | 実 | 3,046 | ↓ | -2.2% | -2.2% | 142 | ↓ | -19.3% | -19.3% | 191 | ↓ | -20.4% | -20.4% | 118 | ↓ | -18.1% | -18.1% |
2014.09 | 2014/02/13 | 当初予 | 3,113 | - | - | - | 176 | - | - | - | 240 | - | - | - | 144 | - | - | - |